Skip to content

Pacing Electrode

by Pacesetter Systems 510(k)

Active United States

510(k) K834431

Overview

The Pacing Electrode is a Permanent Pacemaker Electrode, classified under FDA regulation 870.3680. This device is designed to deliver electrical stimulation to the heart muscle, facilitating cardiac pacing in patients with conduction abnormalities or arrhythmias. It serves as a critical component of a pacemaker system, ensuring proper heart rhythm regulation through direct myocardial stimulation.

Pacing Electrodes are implanted via surgical procedures, typically positioned in the right atrium, right ventricle, or coronary sinus. They are supplied sterile and intended for single-use implantation, though some models may be reusable under specific conditions. The device adheres to FDA 510(k) clearance (K834431) and falls under the DTB product code, with regulatory classification as a Class III medical device. Storage and handling must comply with sterile medical device protocols.

AI-generated from registry data, 18 Sep 2026.Not verified by deviCERTS or the manufacturer

Regulatory status

as of 28 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK834431 Date12 Mar 1984ClearedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DTB
Device Class
Class III
Regulation
21 CFR Part 870.3680
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Other devices from Pacesetter Systems

See all devices from Pacesetter Systems →

Questions

  • What is the primary purpose of this pacing electrode, and where is it typically implanted in the body?

    This pacing electrode is designed to deliver electrical stimulation directly to the heart muscle, helping regulate abnormal heart rhythms or conduction issues in patients. It is typically implanted surgically in the right atrium, right ventricle, or coronary sinus, depending on the patient’s clinical needs and the specific model used.

  • Is this device intended for single-use or can it be reused after implantation?

    The device is primarily supplied sterile and intended for single-use implantation. However, some models may be reusable under specific conditions, though this would depend on manufacturer guidelines and clinical protocols to ensure sterility and safety.

  • How should this pacing electrode be stored, and what precautions should be taken during handling?

    Since this is a sterile medical device, storage and handling must follow strict sterile medical device protocols. It should be kept in its original packaging until ready for use, protected from contamination, and stored in a clean, dry environment to maintain sterility.

  • What regulatory pathway was followed for this device’s approval, and which committee reviewed it?

    This pacing electrode was cleared through the FDA’s 510(k) pathway, specifically under the Traditional clearance type. It was reviewed by the Cardiovascular (CV) Advisory Committee and classified as a Class III medical device, indicating higher regulatory oversight due to its critical role in cardiac pacing.